Melanie Herrmann
Director of Investor Relations
Replay available
Ligand Pharmaceuticals Incorporated (LGND) Q4 2025 Earnings Call
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) Q4 2025 earnings conference call, held 2026-02-26. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Todd Davis
Chief Executive Officer
Tavo Espinoza
Chief Financial Officer
Lauren Hay
Vice President of Portfolio Strategy and Investments
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Ligand Pharmaceuticals Incorporated.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.256 Thank you for standing by and welcome to Ligon 4th Quarter 2025 Earnings Call. 00:00:05.256 -- 00:00:08.460 All lines have been placed on mute to prevent any background noise. 00:00:08.460 -- 00:00:11.302 After the speaker's remarks, there will be a question and answer session. 00:00:11.302 -- 00:00:15.307 If you would like to ask a question during this time, simply press the star followed 00:00:15.307 -- 00:00:17.809 by the number one on your telephone keypad. 00:00:17.809 -- 00:00:20.712 If you would like to withdraw your question, please press the star one again. 00:00:20.712 -- 00:00:25.217 Thank you. I would now like to turn the conference over to Melanie Herrmann, who may 00:00:25.217 -- 00:00:26.643 begin. 00:00:26.643 -- 00:00:31.548 Good morning everyone and welcome to Ligand's fourth quarter and full year 2025 earnings 00:00:31.548 -- 00:00:37.033 call. With me on the call today are CEO Todd Davis, Chief Financial Officer Tavo 00:00:37.033 -- 00:00:42.438 Espinoza, and Vice President of Portfolio Strategy and Investments Lauren Hay. 00:00:42.438 -- 00:00:47.242 During the call today, we will review the financial results released earlier today and 00:00:47.242 -- 00:00:51.946 provide commentary on our partnered portfolio and business development activity, followed 00:00:51.946 -- 00:00:54.869 by a question and answer session. 00:00:54.869 -- 00:00:58.688 Before we get started, I would like to point out that we will be discussing non-GAAP 00:00:58.688 -- 00:01:03.635 results, which exclude certain items such as stock-based compensation, amortization of 00:01:03.635 -- 00:01:08.942 intangible assets, amortization or impairment of financial assets, gains or losses 00:01:08.942 -- 00:01:14.129 from derivative assets, and gain ...